The Venture Codex Logo

The Venture Codex

Mankind Pharma

208, Okhla Industrial Estate, Phase-III, New Delhi, Delhi, 110020, India

Overview

Affordable and accessible medicines for urgent medical needs.

Founded

1995

Deals ยท 12mo

1

Links

WebsiteX (Twitter)

Stage focus

Series A

Geographic focus

Belgium
India
United Kingdom

Sector focus

Health Care
Pharmaceutical

Investment portfolio

7rounds
NAMEDATESIZE
Armed Cell Therapeutics
Oct 2026Led
$54 MOther Equity
Zepto
Nov 2024Participated
$350 MOther Equity
BatX Energies
Dec 2023Participated
$5 MSeries A
Actimed Therapeutics
Jun 2023Participated
$6 MSeries A
Vitraya
Mar 2023Participated
$5 MSeries A
unScript.ai
Oct 2022Participated
$1 MOther Equity
Leverage Edu
Mar 2022Participated
$22 MSeries B
Armed Cell Therapeutics
Oct 2026Led
$54 MOther Equity
Zepto
Nov 2024Participated
$350 MOther Equity
BatX Energies
Dec 2023Participated
$5 MSeries A
Actimed Therapeutics
Jun 2023Participated
$6 MSeries A
Vitraya
Mar 2023Participated
$5 MSeries A
unScript.ai
Oct 2022Participated
$1 MOther Equity
Leverage Edu
Mar 2022Participated
$22 MSeries B
7
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Mankind Pharma: 7 funding rounds are recorded in the selected participation categories.All available history.
Mankind Pharma: 7 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A03
Series B01
Other Equity12

Monthly Deal Activity

Mankind Pharma: 7 deals are recorded across 56 months.All available history.
Mankind Pharma: 7 deals are recorded across 56 months. All available history
MonthDeals
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '221
Nov '220
Dec '220
Jan '230
Feb '230
Mar '231
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '231
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '241
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '261

Sector Breakdown

Mankind Pharma: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Mankind Pharma: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
Professional Services3
E-Commerce & Retail2
AI & Machine Learning2
Consumer & Lifestyle1
Education & Workforce1
Crypto & Blockchain1
Enterprise Software1
Fintech1
Food & Agriculture1
Clean Energy & Sustainability1
Transportation & Logistics1

Deal Size Distribution

Mankind Pharma: 7 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Mankind Pharma: 7 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M3
$10M-$25M1
$25M-$50M0
$50M-$100M1
$100M-$250M0
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Mankind Pharma: India has the largest recorded deal count among the displayed regions (5 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Mankind Pharma: India has the largest recorded deal count among the displayed regions (5 deals). All available history
RegionDeals
India5
Europe2
Mankind Pharma: 20 co-investors are shown, with LetsVenture sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Mankind Pharma: 20 co-investors are shown, with LetsVenture sharing 2 recorded deals. All available history
Co-investorShared deals
LetsVenture2
Adiko Holdings1
AngelList1
Artha Ventures1
Bennett Coleman and Company1
Blume Ventures1
BluSmart1
Cactus Venture Partners1
Cello1
Chona Family Office1
DSG Consumer Partners1
Endurance Capital1
Excel Industries1
Exfinity Venture Partners1
Haldiram's1
Jio Platforms1
JITO Angel Network1
Kaizen Private Equity1
Kalyan1
Motilal Oswal1

Investment Strategy

Mankind Pharma: Led accounts for 14% and participating for 86% of round participation.All available history.
Mankind Pharma: Led accounts for 14% and participating for 86% of round participation. All available history
CategoryDeals (count)Share (%)
Led114%
Participating686%
Mankind Pharma: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Mankind Pharma: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Ajay Bansal

Marketing Director

Arjun Juneja

Director

P.K Arora

Director

R.C Juneja

Chairman, Founder & CEO

Rajeev Juneja

CEO

Sheetal Arora

Managing Director

Tarun Kapoor

Vice President - Digital Transformation